MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
Advertisement
Advertisement
Trending on AJMC
1
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
2
Divergent Cost Trends for 3 Advanced Cancers, 2013 vs 2022: A Commercial Claims Analysis
3
Simulating the Impact of the Transforming Episode Accountability Model
4
Unregulated Peptide Side Effects Easy to Miss: Catherine Varney, DO
5